XTX Topco’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-101,509
Closed -$250K 4407
2026
Q1
$250K Sell
101,509
-39,358
-28% -$132K ﹤0.01% 2650
2025
Q4
$561K Buy
140,867
+68,763
+95% +$304K 0.01% 1489
2025
Q3
$273K Buy
+72,104
New +$245K 0.01% 1580
2024
Q4
Sell
-43,039
Closed -$53.4K 2577
2024
Q3
$53.4K Buy
43,039
+25,163
+141% +$31.5K ﹤0.01% 1685
2024
Q2
$29.9K Sell
17,876
-12,609
-41% -$22.5K ﹤0.01% 1571
2024
Q1
$56.7K Sell
30,485
-5,466
-15% -$10.1K 0.01% 1452
2023
Q4
$68.3K Buy
+35,951
New +$53.7K 0.02% 1190
2023
Q2
Sell
-10,579
Closed -$36.6K 1602
2023
Q1
$36.6K Buy
+10,579
New +$51.2K 0.01% 1191

Other funds holding NBP

XTX Topco's NBP Position: Q2 2026 in Review

XTX Topco sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026, closing a stake of 101,509 shares — an estimated $250K sold.

XTX Topco first reported a position in NBP in Q1 2023 and held it in 8 quarters. The position peaked at $561K in Q4 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • XTX Topco reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 101,509 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $250K.
  • XTX Topco first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2023 and held it in 8 quarters.
  • XTX Topco's NovaBridge Biosciences American Depositary Shares position peaked at $561K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.